Core summary of product characteristics for human plasma-derived and recombinant coagulation factor VIII products - Scientific guideline

This document describes the information to be included in the summary of product characteristics for human plasma derived and recombinant coagulation factor VIII products. It applies to medicinal products that are indicated for use in the treatment and prophylaxis of bleeding in patients with haemophilia A.

Keywords: Human plasma derived coagulation factor VIII products, recombinant coagulation factor VIII products, haemophilia A

Document history - Revision 3

Document history - Revision 1

Topics

How useful was this page?

Add your rating